{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:48:23Z","timestamp":1784958503835,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04437-x","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T05:44:03Z","timestamp":1740721443000},"page":"2579-2594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global research trends on the associations between chronic kidney disease and mitochondria: insights from the bibliometric analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Xinfang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"3","key":"4437_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230512","volume":"15","author":"S Elshahat","year":"2020","unstructured":"Elshahat S, Cockwell P, Maxwell AP, Griffin M, O\u2019Brien T, O\u2019Neill C (2020) The impact of chronic kidney disease on developed countries from a health economics perspective: a systematic scoping review. PLoS ONE 15(3):e0230512","journal-title":"PLoS ONE"},{"issue":"10302","key":"4437_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V (2021) Chronic kidney disease. The lancet 398(10302):786\u2013802","journal-title":"The lancet"},{"key":"4437_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-019-1645-y","volume":"21","author":"M Weldegiorgis","year":"2020","unstructured":"Weldegiorgis M, Woodward M (2020) The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol 21:1\u20139","journal-title":"BMC Nephrol"},{"key":"4437_CR4","first-page":"550","volume-title":"Emerging patient-centered concepts in pain among adults with chronic kidney disease, maintenance dialysis, and kidney transplant, Seminars in nephrology","author":"MB Lockwood","year":"2021","unstructured":"Lockwood MB, Steel JL, Doorenbos AZ, Contreras BN, Fischer MJ (2021) Emerging patient-centered concepts in pain among adults with chronic kidney disease, maintenance dialysis, and kidney transplant, Seminars in nephrology. Elsevier, pp 550\u2013562"},{"issue":"11","key":"4437_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","volume":"18","author":"K Matsushita","year":"2022","unstructured":"Matsushita K, Ballew SH, Wang AY-M, Kalyesubula R, Schaeffner E, Agarwal R (2022) Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol 18(11):696\u2013707","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4437_CR6","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1038\/s41598-020-63443-4","volume":"10","author":"J Jitraknatee","year":"2020","unstructured":"Jitraknatee J, Ruengorn C, Nochaiwong S (2020) Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Sci Rep 10(1):6205","journal-title":"Sci Rep"},{"issue":"1","key":"4437_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","volume":"15","author":"NG Vallianou","year":"2019","unstructured":"Vallianou NG, Mitesh S, Gkogkou A, Geladari E (2019) Chronic kidney disease and cardiovascular disease: is there any relationship? Curr Cardiol Rev 15(1):55\u201363","journal-title":"Curr Cardiol Rev"},{"issue":"11","key":"4437_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143(11):1157\u20131172","journal-title":"Circulation"},{"issue":"20","key":"4437_CR9","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.3390\/ijms222011253","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Agborbesong E, Li X (2021) The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential. Int J Mol Sci 22(20):11253","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4437_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/cells12010088","volume":"12","author":"H-J Ho","year":"2022","unstructured":"Ho H-J, Shirakawa H (2022) Oxidative stress and mitochondrial dysfunction in chronic kidney disease. Cells 12(1):88","journal-title":"Cells"},{"key":"4437_CR11","doi-asserted-by":"publisher","first-page":"627837","DOI":"10.3389\/fphys.2021.627837","volume":"12","author":"H Tirichen","year":"2021","unstructured":"Tirichen H, Yaigoub H, Xu W, Wu C, Li R, Li Y (2021) Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress. Front Physiol 12:627837","journal-title":"Front Physiol"},{"issue":"5","key":"4437_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","volume":"17","author":"C Tang","year":"2021","unstructured":"Tang C, Cai J, Yin X-M, Weinberg JM, Venkatachalam MA, Dong Z (2021) Mitochondrial quality control in kidney injury and repair. Nat Rev Nephrol 17(5):299\u2013318","journal-title":"Nat Rev Nephrol"},{"key":"4437_CR13","doi-asserted-by":"publisher","first-page":"121432","DOI":"10.1016\/j.lfs.2023.121432","volume":"319","author":"A Srivastava","year":"2023","unstructured":"Srivastava A, Tomar B, Sharma D, Rath SK (2023) Mitochondrial dysfunction and oxidative stress: role in chronic kidney disease. Life Sci 319:121432","journal-title":"Life Sci"},{"issue":"7","key":"4437_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2215\/CJN.10320819","volume":"15","author":"JL Gamboa","year":"2020","unstructured":"Gamboa JL, Roshanravan B, Towse T, Keller CA, Falck AM, Yu C, Frontera WR, Brown NJ, Ikizler TA (2020) Skeletal muscle mitochondrial dysfunction is present in patients with CKD before initiation of maintenance hemodialysis. Clin J Am Soc Nephrol 15(7):926\u2013936","journal-title":"Clin J Am Soc Nephrol"},{"key":"4437_CR15","doi-asserted-by":"publisher","first-page":"155194","DOI":"10.1016\/j.metabol.2022.155194","volume":"131","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Hu J, Chen Z, Feng J, Yang X, Liang W, Ding G (2022) Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism 131:155194","journal-title":"Metabolism"},{"issue":"3","key":"4437_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/02537176221103617","volume":"45","author":"M Kumar","year":"2023","unstructured":"Kumar M, George RJ, Anisha PS (2023) Bibliometric analysis for medical research. Ind J Psychol Med 45(3):277\u2013282","journal-title":"Ind J Psychol Med"},{"key":"4437_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","volume":"133","author":"N Donthu","year":"2021","unstructured":"Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM (2021) How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 133:285\u2013296","journal-title":"J Bus Res"},{"issue":"3","key":"4437_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","volume":"57","author":"C Chen","year":"2006","unstructured":"Chen C (2006) CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Tec 57(3):359\u2013377","journal-title":"J Am Soc Inf Sci Tec"},{"issue":"2","key":"4437_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"N Eck","year":"2010","unstructured":"Eck N, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523\u2013538","journal-title":"Scientometrics"},{"issue":"1","key":"4437_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12(1):7\u201311","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"4437_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","volume":"183","author":"L Wang","year":"2023","unstructured":"Wang L, Xu X, Zhang M, Hu C, Zhang X, Li C, Nie S, Huang Z, Zhao Z, Hou FF (2023) Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med 183(4):298\u2013310","journal-title":"JAMA Intern Med"},{"issue":"17","key":"4437_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1089\/ars.2020.8184","volume":"35","author":"T Ebert","year":"2021","unstructured":"Ebert T, Neytchev O, Witasp A, Kublickiene K, Stenvinkel P, Shiels PG (2021) Inflammation and oxidative stress in chronic kidney disease and dialysis patients. Antioxid Redox Signal 35(17):1426\u20131448","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"4437_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.kint.2022.07.004","volume":"102","author":"S Feng","year":"2022","unstructured":"Feng S, Qu Y, Chu B, Chen X, Yang Z, Li P, Wang P, He Q, He Y, Lin T (2022) Novel gold-platinum nanoparticles serve as broad-spectrum antioxidants for attenuating ischemia reperfusion injury of the kidney. Kidney Int 102(5):1057\u20131072","journal-title":"Kidney Int"},{"issue":"4","key":"4437_CR24","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1002\/j.2040-4603.2023.tb00281.x","volume":"13","author":"VP Parvathareddy","year":"2023","unstructured":"Parvathareddy VP, Wu J, Thomas SS (2023) Insulin resistance and insulin handling in chronic kidney disease. Compr Physiol 13(4):5069","journal-title":"Compr Physiol"},{"issue":"3","key":"4437_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","volume":"18","author":"XH Wang","year":"2022","unstructured":"Wang XH, Mitch WE, Price SR (2022) Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol 18(3):138\u2013152","journal-title":"Nat Rev Nephrol"},{"key":"4437_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133289","author":"B Kestenbaum","year":"2020","unstructured":"Kestenbaum B, Gamboa J, Liu S, Ali AS, Shankland E, Jue T, Giulivi C, Smith LR, Himmelfarb J, de Boer IH (2020) Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease. JCI insight. https:\/\/doi.org\/10.1172\/jci.insight.133289","journal-title":"JCI insight"},{"issue":"8","key":"4437_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","volume":"17","author":"H Noels","year":"2021","unstructured":"Noels H, Lehrke M, Vanholder R, Jankowski J (2021) Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nat Rev Nephrol 17(8):528\u2013542","journal-title":"Nat Rev Nephrol"},{"key":"4437_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fphys.2020.00794","volume":"11","author":"L Console","year":"2020","unstructured":"Console L, Scalise M, Giangregorio N, Tonazzi A, Barile M, Indiveri C (2020) The link between the mitochondrial fatty acid oxidation derangement and kidney injury. Front Physiol 11:794","journal-title":"Front Physiol"},{"issue":"9","key":"4437_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41581-021-00429-z","volume":"17","author":"M Carlstr\u00f6m","year":"2021","unstructured":"Carlstr\u00f6m M (2021) Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol 17(9):575\u2013590","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4437_CR30","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/ijms21051647","volume":"21","author":"MR Noh","year":"2020","unstructured":"Noh MR, Jang H-S, Kim J, Padanilam BJ (2020) Renal sympathetic nerve-derived signaling in acute and chronic kidney diseases. Int J Mol Sci 21(5):1647","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4437_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10863-022-09945-4","volume":"54","author":"AC Roginski","year":"2022","unstructured":"Roginski AC, Zemnia\u00e7ak \u00c2B, Marschner RA, Wajner SM, Ribeiro RT, Wajner M, Amaral AU (2022) Disruption of mitochondrial functions involving mitochondrial permeability transition pore opening caused by maleic acid in rat kidney. J Bioenerg Biomembr 54(4):203\u2013213","journal-title":"J Bioenerg Biomembr"},{"issue":"6","key":"4437_CR32","doi-asserted-by":"publisher","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","volume":"319","author":"M Jiang","year":"2020","unstructured":"Jiang M, Bai M, Lei J, Xie Y, Xu S, Jia Z, Zhang A (2020) Mitochondrial dysfunction and the AKI-to-CKD transition. Am J Physiol-Renal Physiol 319(6):F1105\u2013F1116","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"1","key":"4437_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-022-02542-7","volume":"19","author":"H Sun","year":"2022","unstructured":"Sun H, Li X, Chen X, Xiong Y, Cao Y, Wang Z (2022) Drp1 activates ROS\/HIF-1\u03b1\/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease. J Neuroinflammat 19(1):213","journal-title":"J Neuroinflammat"},{"key":"4437_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2022.02.007","volume":"346","author":"P-W Wang","year":"2022","unstructured":"Wang P-W, Pang Q, Zhou T, Song X-Y, Pan Y-J, Jia L-P, Zhang A-H (2022) Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK\/Drp1 signaling pathway in chronic kidney disease. Atherosclerosis 346:36\u201345","journal-title":"Atherosclerosis"},{"key":"4437_CR35","doi-asserted-by":"publisher","first-page":"102860","DOI":"10.1016\/j.redox.2023.102860","volume":"66","author":"S Zhang","year":"2023","unstructured":"Zhang S, Qian S, Liu H, Xu D, Xia W, Duan H, Wang C, Yu S, Chen Y, Ji P (2023) LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity. Redox Biol 66:102860","journal-title":"Redox Biol"},{"key":"4437_CR36","doi-asserted-by":"publisher","first-page":"707006","DOI":"10.3389\/fphar.2021.707006","volume":"12","author":"Q Yang","year":"2022","unstructured":"Yang Q, Xie W, Wang X, Luo J, Zhou Y, Cao H, Sun Q, Jiang L, Yang J (2022) SS31 ameliorates podocyte injury via inhibiting OMA1-mediated hydrolysis of OPA1 in diabetic kidney disease. Front Pharmacol 12:707006","journal-title":"Front Pharmacol"},{"issue":"3","key":"4437_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3892\/ijmm.2013.1232","volume":"31","author":"Y Xu","year":"2013","unstructured":"Xu Y, Ruan S, Wu X, Chen H, Zheng K, Fu B (2013) Autophagy and apoptosis in tubular cells following unilateral ureteral obstruction are associated with mitochondrial oxidative stress. Int J Mol Med 31(3):628\u2013636","journal-title":"Int J Mol Med"},{"key":"4437_CR38","doi-asserted-by":"publisher","first-page":"619730","DOI":"10.3389\/fphys.2020.619730","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Z, Shu S, Cai J, Tang C, Dong Z (2020) AMPK\/mTOR signaling in autophagy regulation during cisplatin-induced acute kidney injury. Front Physiol 11:619730","journal-title":"Front Physiol"},{"key":"4437_CR39","doi-asserted-by":"publisher","first-page":"110949","DOI":"10.1016\/j.biopha.2020.110949","volume":"133","author":"H Yuan","year":"2021","unstructured":"Yuan H, Zheng C, Zhu L, Song Z, Dai L, Hu Q, Wang L, Chen Y, Xiong J (2021) Contribution of TFEB-mediated autophagy to tubulointerstitial fibrosis in mice with adenine-induced chronic kidney disease. Biomed Pharmacother 133:110949","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4437_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12967-022-03629-8","volume":"20","author":"Y-P Lu","year":"2022","unstructured":"Lu Y-P, Zhang Z-Y, Wu H-W, Fang L-J, Hu B, Tang C, Zhang Y-Q, Yin L, Tang D-E, Zheng Z-H (2022) SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease. J Transl Med 20(1):420","journal-title":"J Transl Med"},{"issue":"1","key":"4437_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41419-021-04480-3","volume":"13","author":"BY Nam","year":"2022","unstructured":"Nam BY, Jhee JH, Park J, Kim S, Kim G, Park JT, Yoo T-H, Kang S-W, Yu J-W, Han SH (2022) PGC-1\u03b1 inhibits the NLRP3 inflammasome via preserving mitochondrial viability to protect kidney fibrosis. Cell Death Dis 13(1):31","journal-title":"Cell Death Dis"},{"key":"4437_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140695","author":"V Miguel","year":"2021","unstructured":"Miguel V, Tituana J, Herrero JI, Herrero L, Serra D, Cuevas P, Barbas C, Puyol DR, Marquez-Exposito L, Ruiz-Ortega M, Castillo C, Sheng X, Susztak K, Ruiz-Canela M, Salas-Salvado J, Gonzalez MAM, Ortega S, Ramos R, Lamas S (2021) Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI140695","journal-title":"J Clin Invest"},{"issue":"10","key":"4437_CR43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","volume":"32","author":"T Doke","year":"2022","unstructured":"Doke T, Susztak K (2022) The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development. Trends Cell Biol 32(10):841\u2013853","journal-title":"Trends Cell Biol"},{"issue":"6","key":"4437_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","volume":"15","author":"X Fan","year":"2024","unstructured":"Fan X, Yang M, Lang Y, Lu S, Kong Z, Gao Y, Shen N, Zhang D, Lv Z (2024) Mitochondrial metabolic reprogramming in diabetic kidney disease. Cell Death Dis 15(6):442","journal-title":"Cell Death Dis"},{"key":"4437_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.mito.2020.06.004","volume":"53","author":"CA Castellani","year":"2020","unstructured":"Castellani CA, Longchamps RJ, Sun J, Guallar E, Arking DE (2020) Thinking outside the nucleus: mitochondrial DNA copy number in health and disease. Mitochondrion 53:214\u2013223","journal-title":"Mitochondrion"},{"issue":"3","key":"4437_CR46","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/ijms23031776","volume":"23","author":"PC Braga","year":"2022","unstructured":"Braga PC, Alves MG, Rodrigues AS, Oliveira PF (2022) Mitochondrial pathophysiology on chronic kidney disease. Int J Mol Sci 23(3):1776","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4437_CR47","doi-asserted-by":"publisher","first-page":"244","DOI":"10.23876\/j.krcp.20.082","volume":"39","author":"D Bhatia","year":"2020","unstructured":"Bhatia D, Capili A, Choi ME (2020) Mitochondrial dysfunction in kidney injury, inflammation, and disease: potential therapeutic approaches. Kidney Res Clin Pract 39(3):244","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"4437_CR48","first-page":"8837893","volume":"2020","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Yin J, Chen J, Ma X, Wu M, Liu G, Yao K, Tan B, Yin Y (2020) Mitochondria-targeted antioxidants: a step towards disease treatment. Oxid Med Cell Longev 2020(1):8837893","journal-title":"Oxid Med Cell Longev"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04437-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:25:07Z","timestamp":1757143507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4437"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04437-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not involve human participants, animal subjects, or clinical interventions. Therefore, ethics approval and informed consent were not required. The bibliometric analysis was conducted using publicly available data from the WoSCC database, and no identifiable personal data were included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}